Problem 66 - Cliffs Test Prep NCLEX-RN

Question

A patient with Parkinson’s disease is prescribed an anticholinergic drug. What effect(s) should an anticholinergic agent have on this patient? 1\. a reduction in drooling, sweating, tremors, and depression 2\. increase the activity of acetylcholine, a neurotransmitter 3\. decreases the level of the neurotransmitter dopamine 4\. decreased norepinephrine activity

Step-by-Step Solution

Answer

Option 1: a reduction in drooling, sweating, and tremors.

Step 1: Understanding Anticholinergic Agents

Anticholinergic agents work by inhibiting the action of acetylcholine in the central and the peripheral nervous system. This means they block the neurotransmitter acetylcholine from binding to its receptors.

Step 2: Analyzing the Effects

Anticholinergic drugs are known to reduce symptoms like tremors, drooling, and sweating, which are commonly associated with Parkinson’s disease. They do not target depression directly.

Step 3: Effects on Neurotransmitter Levels

Anticholinergic drugs do not increase the activity of acetylcholine; instead, they inhibit it, so option 2 is incorrect. These drugs do not directly decrease dopamine levels; in fact, Parkinson’s treatment often aims to manage dopamine levels as they are typically low.

Step 4: Evaluating the Options

Option 1 mentions a reduction in drooling, sweating, and tremors, which are effects of anticholinergic drugs. Option 3 is incorrect as it incorrectly states a decrease in dopamine, and option 4 incorrectly associates decreased norepinephrine activity with anticholinergic effects.

Key Concepts

Parkinson's disease

Parkinson's disease is a progressive nervous system disorder that affects movement. It develops gradually, sometimes starting with a barely noticeable tremor in just one hand. However, while tremors are common, the disorder also often causes stiffness or slowing of movement.
The root cause of Parkinson's disease is not entirely understood, but it primarily involves the breakdown or death of nerve cells in a specific region of the brain called the substantia nigra. These nerve cells produce dopamine, a neurotransmitter crucial for regulating movement. As dopamine levels decrease, it becomes harder for the brain to control movement.
Symptoms of Parkinson's often include:

• Tremors or shaking, usually beginning in a limb
• Muscle stiffness, causing pain and reduced range of motion
• Slowed movement, making simple tasks time-consuming
• Impaired posture and balance

Understanding the basic mechanisms behind Parkinson's disease is crucial in developing effective treatments.

Anticholinergic drugs

Anticholinergic drugs are medications that block the action of acetylcholine, a neurotransmitter involved in transmitting messages in the nervous system. These drugs are used to treat a variety of conditions, including respiratory disorders, gastrointestinal issues, as well as neurological conditions like Parkinson's disease.
By inhibiting acetylcholine, anticholinergic drugs help reduce symptoms such as muscle tremors and involuntary movements often seen in Parkinson's patients. They have effects on different parts of the body:

• Relaxing the muscles affected by tremors
• Reducing excessive salivation and sweating
• Possibly impacting memory and cognition, as acetylcholine is also essential in the brain

Although these drugs can help manage motor symptoms, they are not commonly used as the primary treatment due to possible side effects such as dry mouth, urinary retention, and constipation. These side effects stem from the non-selective action of anticholinergic drugs, affecting multiple sites in the body.

Neurotransmitters

Neurotransmitters are chemical messengers that transmit signals across synapses from one nerve cell to another. These signals are crucial for the body's ability to perform a wide range of functions, from muscle contractions to hormone release and mood regulation.
In the context of Parkinson's disease, neurotransmitters play a vital role as imbalances can lead to the condition's motor and non-motor symptoms. Specifically, the interplay between dopamine and acetylcholine becomes important as these two neurotransmitters need to be balanced for smooth and controlled muscle movements.
The main neurotransmitters affected in Parkinson's disease are:

• Dopamine: Essential for controlling movement and coordination.
• Acetylcholine: Involved in muscle activation and also affects mood and motivation.

Understanding neurotransmitters' role helps in designing treatment strategies aimed at restoring balance and improving symptoms.

Acetylcholine

Acetylcholine is a neurotransmitter that plays several roles, both in the central and peripheral nervous systems. In the brain, acetylcholine is vital for learning, memory, and mood regulation. In the body, it helps signal muscles to contract and is also involved in autonomic functions like salivation and heart rate control.
In Parkinson's disease, acetylcholine's role becomes significant as its balance with dopamine shifts due to the reduction of dopamine levels. This imbalance contributes to excessive musculoskeletal activity, leading to symptoms such as tremors and rigidity.
Blocking the action of acetylcholine, as anticholinergic drugs do, can help mitigate some of these symptoms. This makes understanding acetylcholine's function critical in treating the motor symptoms of Parkinson's disease. However, care must be taken as affecting acetylcholine levels can sometimes lead to cognitive side effects, due to its role in brain function.

Dopamine

Dopamine is a key neurotransmitter produced in the substantia nigra, an area of the brain crucial for movement regulation. It is involved in a variety of functions, including reward, motivation, memory, attention, and even regulating mood.
In the context of Parkinson's disease, dopamine's role becomes especially prominent. The death of dopamine-producing neurons leads to decreased levels of this important neurotransmitter, resulting in the movement deficits characteristic of Parkinson’s disease. This biochemical change contributes to the difficulty in initiating movements and the tremors associated with the disease.
Treatment strategies for Parkinson's often focus on restoring dopamine levels or mimicking its action in the brain. Common approaches include:

• Medications like Levodopa that convert into dopamine in the brain
• Dopamine agonists that simulate dopamine effects
• MAO-B inhibitors that decrease the breakdown of brain dopamine

By understanding and addressing dopamine's role, treatments can help alleviate motor symptoms and improve patients' quality of life.